Applied Genetic Technologies (AGTC) Announces Data on Recombinant AAV-AAT as Potential Treatment for AAT Deficiency
Tweet Send to a Friend
Applied Genetic Technologies Corporation (Nasdaq: AGTC) announced data evaluating the use of recombinant AAV-AAT vector gene delivery to muscle in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
